Press
Antibodies in Recovered Victims’ Blood May Hold key to COVID-19 Cure
Written by Catheine Ho, San Francisco Chronicle In the race to develop treatments for the coronavirus, two California…
Read MoreAccessing Patients with In-Home Biospecimen Collection
Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom’s Biocommunique Newsletter With more than 40,000 ongoing global…
Read MoreThis Health Startup Helps Coronavirus Patients Take Part in a COVID-19 Clinical Trial
Brian Neman, CEO and co-founder of Sanguine Biosciences, is bringing the clinical trial into the home. Interview with…
Read MoreIn-Home Specimen Collection Allows Clinical Trials to Continue During the Coronavirus Crisis
Acquiring samples from patients within the comfort of their own homes could help clinical trials move forward during…
Read MoreDrug Company Seeks Boston Blood Donors Who have Recovered from Coronavirus
Written by Jonathan Saltzman, The Boston Globe In an urgent effort to develop a potential vaccine and medicine…
Read MoreHave you recovered from COVID-19?
Written by Gary Robbins, San Diego Tribune Biotech company needs your help with advance research. Vir Biotechnology is…
Read MoreStartUp Health 2020 Interview with Brian Neman, Founder & CEO of Sanguine
Transcript: Logan Plaster: Founder and CEO of Sanguine Biosciences. Brian, why don’t you to come on in? Great…
Read MoreComplex Research Calls for Sophisticated Biobanking Tools
Written by Caroline Seydel, GEN New ideas about biobanking lead to technological upgrades in specimen collection, isolation procedures,…
Read MoreSanguine Biosciences: Challenging the Clinical Research Model
Written by Startup Health Today’s clinical research model is missing the mark. It’s slow, complex and in sore…
Read More